Regulatory Compliance
Our Regulatory Compliance Plan for clinical research in Canada ensures that all aspects of our studies adhere to the stringent regulatory requirements set forth by Canadian authorities.We provide guidance and support to ensure clinical trials comply with all relevant regulatory requirements, including those set by HC, FDA, EMA, and other regulatory bodies.
Our knowledgeable regulatory affairs team is proficient in the regulatory requirements of Health Canada, FDA, EMA, and global agencies, providing comprehensive support in study applications, submissions, approvals, and clinical trial authorization (CTA) applications. With an in-house quality assurance team and adherence to standard operating procedures (SOPs), we consistently meet rigorous regulatory and quality standards.
Canadian Regulations
Ensure
that all clinical research activities at the site are conducted per the relevant Canadian laws and regulations, such as the Food and Drugs Act and its Regulations, the Tri-Council Policy Statement, and the Personal Information Protection and Electronic Documents Act.
Institutional Review Board (IRB) or Research Ethics Board (REB)
All research involving human participants requires approval from an IRB, a committee that reviews and approves the study design, informed consent documents, and other study-related documents. The plan should outline the procedures for submitting and obtaining IRB approval for each study conducted at the site.